Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazufumi Hisamatsu
Evaluating the 21-Gene Assay Recurrence Score® as a Predictor of Clinical Response to 24 Weeks of Neoadjuvant Exemestane in Estrogen Receptor-Positive Breast Cancer
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Related publications
Distribution Patterns of 21-Gene Recurrence Score in 980 Chinese Estrogen Receptor-Positive, HER2-negative Early Breast Cancer Patients
Oncotarget
Oncology
Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Neoadjuvant Endocrine Therapy for Estrogen Receptor–Positive Breast Cancer
JAMA Oncology
Cancer Research
Oncology
Validation of the 21-Gene Test as a Predictor of Clinical Response to Neoadjuvant Hormonal Therapy for ER+, HER2-negative Breast Cancer: The TransNEOS Study
Breast Cancer Research and Treatment
Cancer Research
Oncology
Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
TOP2A RNA Expression and Recurrence in Estrogen Receptor-Positive Breast Cancer
Breast Cancer Research and Treatment
Cancer Research
Oncology
Treatment Decisions in Estrogen Receptor-Positive Early Breast Cancer Patients With Intermediate Oncotype DX Recurrence Score Results
SpringerPlus
Multidisciplinary
Lymph Node Involvement: Positive About the Role of the Recurrence Score in Estrogen-Driven Breast Cancer?
Cancer
Cancer Research
Oncology
The Impact of Oncotype DX® Recurrence Score of Paraffin-Embedded Core Biopsy Tissues in Predicting Response to Neoadjuvant Chemotherapy in Women With Breast Cancer
Breast Disease
Medicine
Cancer Research
Oncology
